To verify whether the HLA‐G expression patterns of patients with ccRCC described above constitute a representative subset of general profiles found in patients with ccRCC, we have compared our results to those obtained for the ‘CAncer GEnome of the KIDney’ (CAGEKID) cohort, which includes a hundred patients with ccRCC that were treated in four different European countries (Czech Republic, United Kingdom, Romania, and Russia). This evidence concerns the gene HLA-G and nonpapillary renal cell carcinoma.